Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer.
Am. J. Surg., May;203(5):649-53 (2012)
Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy.
HPB (Oxford)., Jan;14(1):14-9 (2012)
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.
J. Clin. Oncol., Dec;29(34):4555-60 (2011)
Predicting malignant intraductal papillary mucinous neoplasm: a single-center review.
Am. J. Surg., May;201(5):575-9 (2011)
Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
Ann. Surg. Oncol., Jul;18(7):1947-54 (2011)
Endoscopic ultrasound may be unnecessary in the preoperative evaluation of intraductal papillary mucinous neoplasm.
HPB (Oxford)., Feb;13(2):112-6 (2011)
Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors.
HPB (Oxford)., Jan;13(1):59-63 (2011)
A population-based analysis of surgical and adjuvant therapy for resected gastric cancer: are patients receiving appropriate treatment following publication of the intergroup 0116 results?
Gastrointest Cancer Res., Nov;3(6):233-8 (2009)
Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
Cancer., Jun;116(12):2932-40 (2010)
Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy.
J. Vasc. Surg., Mar;51(3):662-6 (2010)
Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?
J. Am. Coll. Surg., Jan;208(1):87-95 (2009)
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336).
Invest New Drugs., Oct;27(5):469-75 (2009)
Image of the month. Retrorectal cystic hamartoma (tailgut cyst).
Arch Surg., Oct;143(10):1017, 1018 (2008)
Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection?
J. Am. Coll. Surg., Jun;206(3):1167-77 (2008)
Residual treatment disparities after oncology referral for rectal cancer.
J. Natl. Cancer Inst., May;100(10):738-44 (2008)
Diagnostic laparoscopy for patients with potentially resectable pancreatic adenocarcinoma: is it cost-effective in the current era?
J. Gastrointest. Surg., Jul;12(7):1177-84 (2008)
Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship.
Arch Surg., Jan;142(1):23-31; discussion 32 (2007)
Reoperation as a quality indicator in colorectal surgery: a population-based analysis.
Ann. Surg., Jan;245(1):73-9 (2007)
Outcome following surgical therapy for gastrointestinal stromal tumors.
J. Gastrointest. Surg., 10(8):1099-105 (2006 Sep-Oct)
Complications and antireflux medication use after antireflux surgery.
Clin. Gastroenterol. Hepatol., Mar;4(3):299-305 (2006)